secwatch / observer

Material Agreements

Entry into or termination of material definitive agreements (Items 1.01/1.02).

8-K items 1.01, 1.02 JSON
MPLX MPLX LP

MPLX LP entered into New MPLX Credit Agreement with Wells Fargo Bank, National Association, as administrative agent, each of Wells Fargo Securities, LLC, JPMorgan Chase Bank, N.A., Barclays Bank PLC, BofA Securities, Inc., Citibank, N.A., Goldman Sachs Banks USA, Mizuho Bank, Ltd., MUFG Bank, Ltd., RBC Capital Markets, Sumitomo Mitsui Banking Corpora valued at $2.5 billion (effective 2026-04-07).

“On April 7, 2026, MPLX LP, a Delaware master limited partnership (“MPLX”), entered into a $2.5 billion, five-year Revolving Credit Agreement with Wells Fargo Bank, National Association, as administrative agent”
BE Bloom Energy Corp

Bloom Energy Corp entered into Warrant with Oracle Corporation (effective 2026-04-09).

“Warrant As previously disclosed in Bloom Energy Corporation’s (the “Company”) Current Report on Form 8-K filed on October 30, 2025, in connection with the partnership between the Company and Oracle Corporation (“Oracle”) to provide on-site solid state power for AI data centers, subject to the negotiation of a warrant mutually acceptable to the Company and Oracle, the Company agreed to issue to Oracle a warrant (the “Warrant”) to purchase up to an aggregate of 3,531,073 shares (the “Warrant Shares”) of Class A Common Stock, par value $0.0001 per share (the “Class A Common Stock”), of the Company, with an exercise price of $113.28 per share, the closing price of the Class A Common Stock on the New York Stock Exchange on October 28, 2025.”
AHCO AdaptHealth Corp.

AdaptHealth Corp. entered into Credit Agreement with Bank of America, N.A., as administrative agent, the lenders and other parties valued at $450.0 million in revolving loan commitments (effective 2026-04-10).

“On April 10, 2026, AdaptHealth LLC (the “Borrower”), a subsidiary of AdaptHealth Corp., a Delaware corporation (the “Company”), entered into a credit agreement (the “Credit Agreement”) among AdaptHealth Intermediate Holdco LLC, a Delaware limited liability company and Borrower’s direct parent (“Intermediate Holdings”), the Borrower, certain wholly-owned subsidiaries of the Borrower, Bank of America, N.A., as administrative agent, the lenders and other parties party thereto.”
PHGE BiomX Inc.

BiomX Inc. entered into Stock Purchase & Assignment Agreement with Mandragola Ltd (effective 2026-04-13).

“On April 13, 2026, the Company entered into and simultaneously closed on a Stock Purchase & Assignment Agreement (the “SPA”) with Mandragola”
BOLD Boundless Bio, Inc.

Boundless Bio, Inc. terminated Lease Termination Agreement with ARE-10933 North Torrey Pines, LLC valued at $10.0 million (effective 2026-04-13).

“On April 13, 2026, Boundless Bio, Inc. (the "Company") entered into an Agreement for Termination of Lease and Voluntary Surrender of Premises (the "Lease Termination Agreement") with ARE-10933 North Torrey Pines, LLC ("Landlord"), pursuant to which the Company and Landlord agreed to terminate that certain Lease Agreement dated as of December 20, 2021”
IMA ImageneBio, Inc.

ImageneBio, Inc. entered into Securities Purchase Agreement with certain institutional and accredited investors valued at gross proceeds to the Company of approximately $30 million (effective 2026-04-12).

“On April 12, 2026, ImageneBio, Inc., a Delaware corporation (the “Company”), entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain institutional and accredited investors (the “Investors”), pursuant to which the Company agreed to sell and issue pre-funded warrants to purchase shares of the Company’s voting common stock”
Investcorp AI Acquisition Corp.

Investcorp AI Acquisition Corp. entered into Business Combination Agreement with Blue Finance Technology Holding Limited, Beckwell One Limited, Eaton One Limited, and Oliver Larholt as representative (effective 2026-04-08).

“on April 8, 2026, it executed a Business Combination Agreement with Blue Finance Technology Holding Limited ("Blue Finance"), Beckwell One Limited ("New Pubco"), Eaton One Limited ("Merger Sub"), and Oliver Larholt as representative of the Blue Finance shareholders holding 96% of Blue Finance's outstanding capital stock ("Target Representative")”
MINR Minerva Gold Inc.

Minerva Gold Inc. entered into Letter of Intent with Taizhou Sentian Sanitary Ware Co., Ltd. (effective 2026-04-10).

“On April 10, 2026, Minerva Gold Inc., a Nevada corporation (the “Company” ), entered into a Letter of Intent (the “Letter of Intent” ) to acquire Taizhou Sentian Sanitary Ware Co., Ltd. ( “Taizhou Sentian” ), a company owned by the Company’s Sole Officer and Director, Zhang Chengcheng.”
ANGX Angel Studios, Inc.

Angel Studios, Inc. entered into Underwriting Agreement with Roth Capital Partners, LLC valued at approximately $28.0 million (effective 2026-04-10).

“On April 10, 2026, Angel Studios, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”), between the Company and Roth Capital Partners, LLC, as the representative of the several underwriters listed on Schedule I thereto (the “Underwriters”), for the issuance and sale by the Company of 14,300,000 shares of its Class A common stock, par value $0.0001 per share (the “Common Stock”) at a price to the public of $2.10 per share (the “Offering”).”
ESGH ESG Inc.

ESG Inc. entered into Split-Off and Share Exchange Agreement with DCG China Limited, Christopher Alonzo, Ever Vast Development Ltd., Weiwei Gao valued at distribution of 100% of ESG China shares in exchange for surrender of 10,432,800 shares of common st (effective 2026-04-10).

“On April 10, 2026, ESG Inc., a Nevada corporation (the “ Company”), entered into a Split-Off and Share Exchange Agreement (the “ Split-Off Agreement”) with DCG China Limited ( “ DCG”), Christopher Alonzo ( “ Alonzo”), Ever Vast Development Ltd. ( “ Ever Vast”), and Weiwei Gao ( “ Gao”).”
CHE CHEMED CORP

CHEMED CORP entered into Sixth Amended and Restated Credit Agreement with JPMorgan Chase Bank, N.A. valued at $450 million (effective 2026-04-10).

“On April 10, 2026, Chemed Corporation (“Chemed” or "we") renewed our $450 million senior secured credit facilities (“Credit Facilities”).”
Third Point Private Capital Partners

Third Point Private Capital Partners entered into Subscription Agreement with Delticus Opportunities Fund LLC valued at $40,000,000 (effective 2026-04-07).

“On April 7, 2026, the Fund entered into a subscription agreement (the “ Subscription Agreement ”) with Delticus Opportunities Fund LLC, an affiliate of Third Point Private Capital LLC, the Fund’s investment adviser, pursuant to which the investor committed to purchase shares of the Fund’s Class I common stock, par value $0.001 per share (the “ Shares ”), in an aggregate amount of up to $40,000,000.”
Third Point Private Capital Partners

Third Point Private Capital Partners entered into SCF Credit Agreement with Goldman Sachs Bank USA valued at $20,000,000 (effective 2026-04-07).

“On April 7, 2026, TP Private Capital Partners SPV II (SCF) LLC (“ SPV II ”), a wholly-owned subsidiary of the Fund, entered into a senior secured revolving credit facility (the “ SCF Credit Facility ”) pursuant to a Credit Agreement (the “ SCF Credit Agreement ”) with Goldman Sachs Bank USA, as administrative agent and lender.”
Third Point Private Capital Partners

Third Point Private Capital Partners entered into ABL Credit Agreement with Goldman Sachs Bank USA valued at $150,000,000 (effective 2026-04-07).

“On April 7, 2026, TP Private Capital Partners SPV I (FLCF) LLC (“ SPV I ”), a wholly-owned subsidiary of Third Point Private Capital Partners (the “ Fund ”), entered into a senior secured credit facility (the “ ABL Credit Facility ”) pursuant to a Credit Agreement (the “ ABL Credit Agreement” ) with Goldman Sachs Bank USA, as administrative agent and lender.”
PMI Picard Medical, Inc.

Picard Medical, Inc. entered into Purchase Agreement with Quick Capital, LLC valued at $555,555.56 (effective 2026-04-07).

“On April 7, 2026, Picard Medical, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with Quick Capital, LLC, a Wyoming limited liability company (the “Buyer”), an accredited investor, for the issuance and sale of a convertible promissory note in the principal face amount of $555,555.56”
VWAV VisionWave Holdings, Inc.

VisionWave Holdings, Inc. entered into Asset Purchase Agreement with Dream America Marketing Services, Ltda. (effective 2026-04-10).

“On April 10, 2026, VisionWave Holdings, Inc. (the “Company”) entered into an Asset Purchase Agreement (the “Agreement”) with Dream America Marketing Services, Ltda., a Costa Rican company (the “Seller”).”
LEG LEGGETT & PLATT INC

LEGGETT & PLATT INC entered into Agreement and Plan of Merger with Somnigroup International Inc. and Sparrow Unity Corporation (effective 2026-04-13).

“On April 13, 2026, Somnigroup International Inc., a Delaware corporation (“ Parent ”), and Leggett & Platt, Incorporated, a Missouri corporation (the “ Company ”), entered into an Agreement and Plan of Merger (the “ Merger Agreement ”), by and among Parent, Sparrow Unity Corporation, a Missouri corporation and a direct, wholly owned subsidiary of Parent (“ Merger Sub ” and together with Parent, the “ Parent Parties ”), and the Company”
HCSG HEALTHCARE SERVICES GROUP INC

HEALTHCARE SERVICES GROUP INC entered into Second Amendment to Credit Agreement with PNC Bank, National Association valued at Amendment extended maturity to April 7, 2031 and added daily SOFR rate option (effective 2026-04-07).

“Healthcare Services Group, Inc. (the “Company”) entered into a Second Amendment, dated April 7, 2026 (the “Second Amendment”), to its existing Credit Agreement, dated December 21, 2018, as amended on November 22, 2022 (the “Credit Agreement”), by and among the Company, its wholly-owned subsidiaries (other than HCSG Insurance Corp.), the several banks and other financial institutions or entities that are from time to time parties thereto, and PNC Bank, National Association, as administrative agent.”
CLRO CLEARONE INC

CLEARONE INC terminated Termination Agreement with Edgewater Corporate Park, LLC valued at $300,000 termination fee (effective 2026-04-07).

“On April 7, 2026, ClearOne, Inc. (the “Company”) entered into a lease termination agreement (the “Termination Agreement”) with Edgewater Corporate Park, LLC (the “Landlord”) pursuant to which the Company terminated its lease for its corporate offices located at 5225 Wiley Post Way in Salt Lake City, Utah for a $300,000 termination fee (the “Termination Fee”).”
WYY WIDEPOINT CORP

WIDEPOINT CORP entered into At The Market Offering Agreement with H.C. Wainwright & Co., LLC valued at up to $15.5 million (effective 2026-04-10).

“On April 10, 2026, WidePoint Corporation (the “Company” or “us” or “we”) entered into an At The Market Offering Agreement (the “Sales Agreement”) with H.C. Wainwright & Co., LLC (the “Sales Agent”) under which we may issue and sell in a registered offering shares of our common stock having an aggregate offering price of up to $15.5 million from time to time through or to the Sales Agent (the “ATM Offering”).”
APCX AppTech Payments Corp.

AppTech Payments Corp. entered into Purchase Agreements with LendSpark Corporation and Manetto Hill Fund Series I, LLC valued at $500,000 (effective 2026-04-03).

“On April 3, 2026, AppTech Payments Corp. (the “Company”) entered into securities purchase agreements (the “Purchase Agreements”) with each of LendSpark Corporation (“LendSpark”) and Manetto Hill Fund Series I, LLC (“Manetto,” and together with LendSpark, the “Investors”), pursuant to which each Investor agreed to purchase, and the Company agreed to issue and sell to such Investor, an 18% promissory note in the principal amount of $500,000”
CXW CoreCivic, Inc.

CoreCivic, Inc. amended Second Amendment to Fourth Amended and Restated Credit Agreement with certain subsidiaries of the Company party thereto, the lenders party thereto and Alter Domus Products Corp., as Administrative Agent valued at $100 million (effective 2026-04-10).

“On April 10, 2026, CoreCivic, Inc., a Maryland corporation (the “Company”), entered into a Second Amendment to Fourth Amended and Restated Credit Agreement dated as of April 10, 2026 (the “Second Amendment”), by and among the Company, as Borrower, certain subsidiaries of the Company party thereto, the lenders party thereto and Alter Domus Products Corp., as Administrative Agent (the “Administrative Agent”), which amends that certain Fourth Amended and Restated Credit Agreement dated October 11, 2023, by and among the Company, the lenders from time to time party thereto, and the Administrative Agent, as agent for the lenders (as amended from time to time, the “Credit Facility”).”
LYRA Lyra Therapeutics, Inc.

Lyra Therapeutics, Inc. terminated 880 Winter Street Lease with BXP Waltham Woods LLC valued at Forfeiture of $1,089,389.00 letter of credit security deposit and payment of $1,500,000.00 terminati (effective 2026-04-07).

“On April 7, 2026, the Company entered into a Lease Termination Agreement with BXP Waltham Woods LLC to terminate the Company’s lease for approximately 28,858 rentable square feet at 880 Winter Street, Waltham, Massachusetts.”
LYRA Lyra Therapeutics, Inc.

Lyra Therapeutics, Inc. terminated 480 Arsenal Street Lease with ARE-480 Arsenal Street, LLC valued at Forfeiture of $302,514.84 letter of credit security deposit and payment of $1,000,000.00 lease modif (effective 2026-03-31).

“On March 31, 2026, Lyra Therapeutics, Inc. (the “Company”) entered into an Agreement for Termination of Lease and Voluntary Surrender of Premises with ARE-480 Arsenal Street, LLC to terminate the Company’s lease for approximately 22,343 rentable square feet at 480 Arsenal Way, Suites 200 and 200A, Watertown, Massachusetts.”
AFS SENSUB CORP.

AFS SENSUB CORP. entered into Underwriting Agreement with J.P. Morgan Securities LLC, BMO Capital Markets Corp., BofA Securities, Inc., Citigroup Global Markets Inc., Lloyds Securities Inc., BNP Paribas Securities Corp., Cabrera Capital Markets, LLC, Scotia Capital (USA) Inc. and SMBC Nikko Securities America, Inc. (effective 2026-04-08).

“pursuant to the Underwriting Agreement attached hereto as Exhibit 1.1 , dated as of April 8, 2026 (the “ Underwriting Agreement ”), among GM Financial, AFS SenSub and the Representative.”
MRAM EVERSPIN TECHNOLOGIES INC.

EVERSPIN TECHNOLOGIES INC. entered into Foundry Services Agreement with Microchip Technology valued at Estimated total reimbursement of approximately $13.95 million in two phases for costs; minimum purch (effective 2026-04-08).

“On April 8, 2026, Everspin Technologies, Inc. (the “Company”) and Microchip Technology (“Microchip”) entered into a Foundry Services Agreement (the “Agreement”). Under the Agreement, Microchip will manufacture 8-inch Magnetoresistive Random Access Memory (“MRAM”), Tunnel Magnetoresistive (“TMR”) sensor, and Spin-transfer Torque (“STT”) MRAM wafers for the Company at Microchip’s Fab 4 facility located in Gresham, Oregon.”
ANVS Annovis Bio, Inc.

Annovis Bio, Inc. entered into Underwriting Agreement with Canaccord Genuity LLC valued at Combined offering price of $1.90 per Share and accompanying Warrant, gross proceeds ~$10 million (effective 2026-04-09).

“On April 9, 2026, Annovis Bio, Inc. (the “Company”) entered into (i) an Underwriting Agreement (the “Underwriting Agreement”), dated as of April 9, 2026, with Canaccord Genuity LLC, as underwriter (the “Underwriter”), pursuant to which the Company agreed to issue and sell, in an underwritten registered direct offering (the “Offering”) (i) an aggregate of 5,263,156 shares of common stock (the “Shares”), $0.0001 par value per share (the “Common Stock”), of the Company and (ii) accompanying common stock warrants to purchase an aggregate of 5,263,156 shares of Common Stock (the “Warrants” and the shares of Common Stock issuable upon exercise of the Warrants, the “Warrant Shares”).”
CVSI CV Sciences, Inc.

CV Sciences, Inc. entered into Third Note with the Investor valued at Principal amount $99,614.04, due April 6, 2027 (later extended) (effective 2026-04-06).

“disclosed, on February 12, 2025, CV Sciences, Inc., a Delaware corporation (the “Company”) entered into a note purchase agreement (the “Original Purchase Agreement”) with an institutional investor (“Investor”), pursuant to which the Company issued and sold to the Investor a secured promissory note in the original principal amount of $1,600,000 (the “Original Note”).”
CVSI CV Sciences, Inc.

CV Sciences, Inc. amended April Amendment with the Investor valued at Third Note principal amount $99,614.04; conversion price changed to $0.03 per share; maturity date o (effective 2026-04-09).

“On April 9, 2026, the Company and the Investor entered into an agreement (the "April Amendment") to amend the Notes to implement a new fixed conversion price equal to $0.03 per share.”
Livento Group, Inc.

Livento Group, Inc. entered into a notes offering with AES CAPITAL MANAGEMENT, LLC valued at $30,000 (effective 2025-09-11).

“On September 11, 2025 the company entered financing agreement with AES CAPITAL MANAGEMENT, LLC in amount of $30,000, with interest at the rate of eight percent (8%) per annum with maturity date on September 11, 2026.”
CFTR-PA Cantor Fitzgerald Income Trust, Inc.

Cantor Fitzgerald Income Trust, Inc. entered into First Amendment to Second Amended and Restated Limited Partnership Agreement of Cantor Fitzgerald Income Trust Operating Partnership, L.P. with Cantor Fitzgerald Income Trust Operating Partnership, L.P. valued at Established new series of ownership interest designated as Series A Preferred Units in connection wi (effective 2026-04-08).

“On April 8, 2026, in connection with the issuance and sale by Cantor Fitzgerald Income Trust, Inc. (the “ Company ”) of the Company’s new class of 9.50% Series A Cumulative Redeemable Preferred Stock, par value $0.01 per share (the “ Series A Preferred Stock ”) in an underwritten public offering (the “ Offering ”), the Company, in its capacity as the general partner of Cantor Fitzgerald Income Trust Operating Partnership, L.P., entered into First Amendment to Second Amended and Restated Limited Partnership Agreement of Cantor Fitzgerald Income Trust Operating Partnership, L.P. (“ Amendment No. 1 ”).”
DK Delek US Holdings, Inc.

Delek US Holdings, Inc. amended Amendment No. 4 to Third Amended and Restated Credit Agreement with Wells Fargo Bank, National Association (effective 2026-04-09).

“On April 9, 2026, Delek US Holdings, Inc. (the “Company”) entered into Amendment No. 4 to Third Amended and Restated Credit Agreement (“Amendment No. 4”) among the Company, as borrower, certain wholly-owned subsidiaries of the Company, as guarantors, Wells Fargo Bank, National Association, as administrative agent and certain other lenders party thereto.”
PHGE BiomX Inc.

BiomX Inc. entered into Stock Purchase Agreement with Water IO Ltd. valued at $1,250,000 (effective 2026-04-10).

“On April 10, 2026, BiomX Inc. (NYSE American: PHGE) (the “Company”) entered into and simultaneously closed a definitive Stock Purchase Agreement (the “SPA”) with Water IO Ltd. (“Water IO”), a publicly traded Israeli company listed on the Tel Aviv Stock Exchange, pursuant to which the Company acquired 100% of the issued and outstanding share capital of Zorro Net Ltd.”
SPIR Spire Global, Inc.

Spire Global, Inc. entered into Registration Rights Agreement with the Purchasers (effective 2026-04-08).

“in addition, on April 8, 2026, the Company and the Purchasers entered into a registration rights agreement (the “Registration Rights Agreement”), pursuant to which the Company agreed to file the Registration Statement with the SEC on or before April 23, 2026 for purposes of registering the resale of the Shares, to use its reasonable best efforts to have such Registration Statement declared effective no later than May 8, 2026, and to keep the Registration Statement effective until the date that all registrable securities covered by the Registration Statement (i) have been sold, thereunder or pursuant to Rule 144, or (ii) may be sold without volume or manner-of-sale restrictions pursuant to Rule 144 and without the requirement for the Company to be in compliance with the current public information requirement under Rule 144.”
SPIR Spire Global, Inc.

Spire Global, Inc. entered into Purchase Agreement with certain accredited investors valued at $70.0 million (effective 2026-04-08).

“On April 8, 2026, Spire Global, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with the purchasers named therein (the “Purchasers”), for the private placement (the “Private Placement”) of 5,000,000 shares (the “Shares”) of the Company’s Class A common stock, par value $0.0001 per share (the “Common Stock”), at a purchase price of $14.00 per Share.”
BOXABL Inc.

BOXABL Inc. entered into Second Amendment to the Merger Agreement with FG Merger II Corp. and FG Merger Sub II Inc. valued at Amendment to extend the Agreement End Date from March 31, 2026 to July 31, 2026; release of lock-up (effective 2026-04-06).

“On April 6, 2026, BOXABL Inc. (“ BOXABL ”) entered into a Second Amendment (the “ Second Amendment ”) to that certain Agreement and Plan of Merger, dated as of August 4, 2025, as amended by the First Amendment to the Agreement and Plan of Merger dated November 3, 2025 (collectively, the “ Merger Agreement ”), by and among BOXABL, FG Merger II Corp. (“ FGMC ”), and FG Merger Sub II Inc. (“ Merger Sub ” and together with BOXABL and FGMC, the “ Parties ”).”
NXXT NEXTNRG, INC.

NEXTNRG, INC. entered into Leviston SPA with Leviston Resources, LLC valued at principal amount of $1,724,444 (effective 2026-04-01).

“On April 1, 2026, NextNRG, Inc. (the “Company”) and Leviston Resources, LLC (“Leviston”) entered into a Securities Purchase Agreement dated as of April 1, 2026 (the “Leviston SPA”), pursuant to which the Company agreed to sell, and Leviston agreed to purchase, a senior secured convertible promissory note in the principal amount of $1,724,444 (the “Leviston Note”) for a purchase price of $1,552,000.”
HCTI Healthcare Triangle, Inc.

Healthcare Triangle, Inc. entered into Platform Development Agreement with SecureKloud Technologies Limited (effective 2026-03-31).

“On April 7, 2026, Healthcare Triangle, Inc., a Delaware corporation (the “ Company ”), entered into a Platform Development Agreement (the “ Agreement ”) with SecureKloud Technologies Limited, an Indian corporation (“ SKL ”), as lead contractor, and Blockedge Technologies Inc., a subsidiary of SKL (“ Blockedge ”), as sub-contractor. The Agreement is made effective as of March 31, 2026.”
JTAI Jet.AI Inc.

Jet.AI Inc. entered into Equity Certificates Subscription Agreement with VERSO Capital 2 SCSP valued at $5,250,000 (effective 2026-04-07).

“Jet.AI Inc. (the “Company”) entered into an Equity Certificates Subscription Agreement (the “Subscription Agreement”) with VERSO Capital 2 SCSP (“Verso”) to subscribe for 8,347 equity certificates (the “Certificates”) in Verso for an aggregate subscription price equal to $5,250,000”
AMOD ALPHA MODUS HOLDINGS, INC.

ALPHA MODUS HOLDINGS, INC. entered into Exchange Agreement with the family trust of the Company’s CEO, William Alessi (effective 2026-04-08).

“On April 8, 2026, Alpha Modus Holdings, Inc. (the “ Company ”) entered into an exchange agreement (the “ Exchange Agreement ”) with the family trust of the Company’s CEO, William Alessi, pursuant to which the trust will exchange an aggregate of 3,870,000 shares of Series C Preferred Stock (the “ Preferred Shares ”) for an aggregate of 109,588,265 shares of Class A common stock”
SNAL Snail, Inc.

Snail, Inc. entered into Software Development Outsourcing Agreement with Suzhou Snail Digital Technology Co., Ltd. valued at aggregate $1.966 million in four quarterly installments of $491,500 (effective 2026-04-06).

“On April 6, 2026, the Company entered into a Software Development Outsourcing Agreement (the “Development Agreement”) with Suzhou Snail Digital Technology Co., Ltd. (“Suzhou Snail”) through the Company’s wholly-owned subsidiary, Snail Games USA, Inc.”
SNAL Snail, Inc.

Snail, Inc. entered into Amendment No. 3 to the Amended and Restated Exclusive Software License Agreement with SDE Inc. valued at reduced licensing fees to $1.5 million per month, replaces certain one-time DLC payments with $5 mil (effective 2026-04-01).

“On April 6, 2026, Snail, Inc., a Delaware corporation, (the “Company”) entered into Amendment No. 3 to the Amended and Restated Exclusive Software License Agreement (the “Amendment”) with SDE Inc., a California corporation (“SDE”) through the Company’s wholly-owned subsidiary, Snail Games USA, Inc.”
FGMC FG Merger II Corp.

FG Merger II Corp. amended Amendment with BOXABL Inc., FG Merger Sub II Inc. (effective 2026-04-06).

“On April 6, 2026, FG Merger II Corp. (“ FGMC ”), entered into an Amendment (the “ Amendment ”) to that certain Agreement and Plan of Merger, dated as of August 4, 2025 (as amended on November 3, 2025, the “ Merger Agreement ”), by and among FGMC, BOXABL Inc., (“ BOXABL ”) and FG Merger Sub II Inc. (“ Merger Sub ” and together with BOXABL and FGMC, the “ Parties ”).”
Stepstone Private Credit Fund LLC

Stepstone Private Credit Fund LLC terminated MassMutual SPV I Facility with Massachusetts Mutual Life Insurance Company and Massachusetts Ascend Life Insurance Company (effective 2026-04-06).

“On April 6, 2026, SPV Facility I LLC (“SPV Facility I”), a wholly-owned subsidiary of StepStone Private Credit Fund LLC (the “Company”), and the Company executed a termination agreement (the “Termination Agreement”), terminating the Loan and Servicing Agreement”
NTHI NEONC TECHNOLOGIES HOLDINGS, INC.

NEONC TECHNOLOGIES HOLDINGS, INC. entered into Equity Distribution Agreement with BTIG, LLC and A.G.P./Alliance Global Partners valued at $75,000,000 (effective 2026-04-10).

“On April 10, 2026, the Company entered into an Equity Distribution Agreement (the “Agreement”) with BTIG, LLC and A.G.P./Alliance Global Partners (collectively, the “Placement Agents”) to create an “at the market” equity program under which it may sell up to an aggregate of $75,000,000 of shares of the Company’s common stock”
VG Venture Global, Inc.

Venture Global, Inc. entered into Term Loan B Facility valued at $1,750,000,000 (effective 2026-04-10).

“entered into a senior secured term loan B facility in an initial principal amount equal to $1,750,000,000 (the “Term Loan B Facility”)”
DYNC Dynamix Corp

Dynamix Corp entered into Termination Agreement with Dynamix Corporation, The Ether Machine, Inc., ETH SPAC Merger Sub Ltd., The Ether Reserve LLC, Ethos Sub 1, Inc., Ethos Sub 2, Inc., Ethos Sub 3, Inc., ETH Partners LLC, DynamixCore Holdings, LLC, and the party named on Annex A valued at $50,000,000 (effective 2026-04-08).

“Pursuant to the Termination Agreement, the Payor is required to pay Dynamix $50,000,000 within 15 days of the Effective Date”
DYNC Dynamix Corp

Dynamix Corp terminated Sponsor Support Agreement with DynamixCore Holdings, LLC, Dynamix Corporation, The Ether Machine, Inc. (effective 2026-04-08).

“(ii) the Sponsor Support Agreement, dated as of July 21, 2025, by and among the Sponsor, Dynamix and Pubco (the “Sponsor Support Agreement”), in each case pursuant to the terms of the Termination Agreement”
DYNC Dynamix Corp

Dynamix Corp terminated Business Combination Agreement with The Ether Machine, Inc., ETH SPAC Merger Sub Ltd., The Ether Reserve LLC, Ethos Sub 1, Inc., Ethos Sub 2, Inc., Ethos Sub 3, Inc., ETH Partners LLC, DynamixCore Holdings, LLC (effective 2026-04-08).

“On April 8, 2026 (the “Effective Date”), Dynamix Corporation, a Cayman Islands exempted company (“Dynamix”), The Ether Machine, Inc., a Delaware corporation (“Pubco”), ETH SPAC Merger Sub Ltd., a Cayman Islands exempted company (“SPAC Merger Sub”), The Ether Reserve LLC, a Delaware limited liability company (the “Company”), Ethos Sub 1, Inc., a Delaware corporation and a wholly owned subsidiary of SPAC (“SPAC Subsidiary A”), Ethos Sub 2, Inc., a Delaware corporation and a wholly owned subsidiary of SPAC Subsidiary A (“SPAC Subsidiary B”), Ethos Sub 3, Inc., a Delaware corporation and a wholly owned subsidiary of SPAC Subsidiary B (“Company Merger Sub” and, together with SPAC Subsidiary A and SPAC Subsidiary B, the “SPAC Subsidiaries” and each, a “SPAC Subsidiary”), ETH Partners LLC, a Delaware limited liability company (the “Seller”), DynamixCore Holdings, LLC, a Delaware limited liability company (the “Sponsor”), and the party named on Annex A thereto (the “Payor”), entered into a Ter”
AEBI Aebi Schmidt Holding AG

Aebi Schmidt Holding AG amended Amendment No. 1 to the Relationship Agreement with Peter Spuhler and PCS Holding AG (PCS Parties) (effective 2026-04-07).

“On April 7, 2026, Aebi Schmidt and the PCS Parties entered into Amendment No. 1 to the Relationship Agreement, which amended the Relationship Agreement to, among other things, (i) provide that, if Aebi Schmidt’s Board of Directors (the “Board”) consists of eight members, then the PCS Parties shall have a right to nominate (a) three directors if they own at least 35% of the outstanding shares of Aebi Schmidt common stock, (b) two directors if they own at least 25% (but less than 35%) of the outstanding shares of Aebi Schmidt common stock, (c) two directors if they own at least 15% (but less than 25%) of the outstanding shares of Aebi Schmidt common stock and (d) one director if they own at least 12.5% (but less than 15%) of the outstanding shares of Aebi Schmidt common stock and (ii) allow the Chief Executive Officer of Aebi Schmidt to also hold the position of Chair of the Board.”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.